TORONTO (Reuters) – Canada’s public broadcaster has won the rights to cover the 2018 and 2020 Olympics with the help of the two rival private broadcasters that have wrestled its most popular professional sports assets away from it.
The Canadian Broadcasting Corp (CBC) said on Tuesday it will broadcast action from the 2018 Winter Olympics in Pyeongchang, South Korea, and the 2020 Summer Olympics in Tokyo, in partnership with telecom and media companies Rogers Communications Inc and BCE Inc.
TORONTO (Reuters) – Canada’s biggest stock exchange operator plans to offer trading options for investors who fear speed-based computer strategies are undercutting them, a move it hopes will keep clients from leaving for rival marketplaces.
TORONTO, Oct 23 (Reuters) – Canadian telecom and media
company Rogers Communications Inc posted a 28 percent
decline in third-quarter net income on Thursday, but reaffirmed
its profit targets for the year as it heralded the end of a
Rogers, the country’s largest provider of cellular service,
added just 17,000 net wireless subscribers on contracts, who
typically spend more per month and are less likely to switch
providers than those who pay for service upfront.
CALGARY/TORONTO (Reuters) – A gun attack targeting the heart of Canada’s government has shaken the country’s closely guarded image as a sanctuary from the kinds of mass violence that plague the United States.
Canadian cities and towns hiked security around government buildings, schools and mass transit systems on Wednesday after a gunman entered Ottawa’s parliament building, leading to gunfire near a room where Prime Minister Stephen Harper was holding a meeting. The gunman was shot and killed.
TORONTO (Reuters) – Billionaire investor William Ackman turned up the heat on Allergan Inc. on Thursday when he accused the Botox maker’s board of misleading investors to fend off a hostile takeover bid from Valeant Pharmaceuticals.
Ackman, whose hedge fund Pershing Square Capital Management is Allergan’s biggest shareholder, told reporters that his lawyers had seen documents that show Allergan’s board knowingly released misleading statements about Valeant.